Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells (Scientific Reports, (2017), 7, 1, (16345), 10.1038/s41598-017-16558-0)

Rand Arafeh, Karen Flores, Alona Keren-Paz, Galia Maik-Rachline, Naomi Gutkind, Steven Rosenberg, Rony Seger, Yardena Samuels*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to the Acknowledgements section of Scientific Reports https://doi.org/10.1038/s41598-017-16558-0, published online 27 November 2017. The error has not been fixed in the paper.

Original languageEnglish
Article number4672
Number of pages1
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - 12 Mar 2019

Funding

Y.S. is supported by the Israel Foundation grant numbers 711631, the ERC (StG-335377), The Minerva Foundation Grant, the MRA and by the Knell Family and the Hamburger Family. This work was supported by ISF and BSF to RS. R.S. is an incumbent of the Yale S. Lewine and Ella Miller Lewine Professional Chair for Cancer Research. R.A. is supported by the Clore Foundation. Rand Arafeh and Karen Flores contributed equally.

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells (Scientific Reports, (2017), 7, 1, (16345), 10.1038/s41598-017-16558-0)'. Together they form a unique fingerprint.

Cite this